Aktis Oncology, Inc. Common stock (AKTS)
Healthcare
Biotechnology
22.20 $
+0.7%
vs. previous close
Closing price · As of: 3. Aug 2026
Investor relations overview for Aktis Oncology, Inc. Common stock (AKTS): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 08/10/2026.
Report Dates
Next report
08/10/2026
Last report
05/11/2026
Earnings Call Transcripts
No transcripts yet — they will show up here automatically after the next earnings call.
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.